Hypertension Clinical Trial
Official title:
Social Norms and Antihypertensive Medication Adherence
The study objective is to build group social norms to improve individual adhere to antihypertensive medications. Financial incentives are provided to individuals contingent upon group behavioral changes. Groups of patients will be formed, and incentivized to interact on a daily basis through social media and participate in a monthly-facilitated meeting at a local clinic. By forming groups, making individual outcomes transparent, and setting financial incentives contingent to group targets, individual decisions are framed within emerging social norms.
We propose a pilot study that will inform, provide inputs and reduce the risk of a larger
implementation. The project consists of three phases: The pre-intervention phase, the
intervention phase, and the post-intervention phase. The pre-intervention phase includes the
recruitment and selection of participants, and a one-month collection of baseline blood
pressure and medication adherence levels of participants before they are assigned to a
treatment arm. All participants will receive compensation for participation.
In the intervention phase participants will be randomly assigned to one of the three
treatment arms and they will receive the financial incentive that corresponds to their
treatment arm. Data will be collected for four months and all participants will continue
receiving a compensation for participation.
During the post-intervention phase, contingency payments will be cut off, and only
compensation for participation will remain. Data will be collected for three months in the
post-intervention phase.
The primary outcome of the study is medication adherence which will be measured using two
different methods. The first method is through the use of eCaps (electronic caps). The second
method is through a monthly randomized phone call during which the participant will be asked
to perform a pill count of their medication.
The secondary outcome of the study is blood pressure which will be measured using two
different instruments . The first instrument will be the ambulatory blood pressure monitor
(ABPM). The second instrument will be a home blood pressure monitor (HBPM) which researchers
will provide to the participant to use for the duration of the study.
All participants of the study will receive an unconditional payment each time they provide a
blood pressure reading from the ABPM. Financial incentives (contingent to change in behavior
-conditional to change in adherence). In addition to the unconditional payment, participants
in the ICM and GCM treatment arms will receive a financial incentive that is conditional to
medication adherence.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |